ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Neurelis Completes Pre-IND Meeting with FDA for Acute Agitation Treatment
December 09, 2020Neurelis has concluded a pre-Investigational New Drug (IND) Application meeting with the U.S. Food and Drug Administration (FDA) regarding NRL-4. The FDA provided direction for the clinical development pathway for the investigational treatment. -
FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment
January 14, 2020Neurelis, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Valtoco (diazepam nasal spray) as an acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, seizure clusters, acute repetitive seizure
Pharma Sources Insight January 2025
